NKTR icon

Nektar Therapeutics

225 hedge funds and large institutions have $692M invested in Nektar Therapeutics in 2022 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 79 increasing their positions, 59 reducing their positions, and 45 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership:

less funds holding

Funds holding:

18% less first-time investments, than exits

New positions opened: 37 | Existing positions closed: 45

27% less capital invested

Capital invested by funds: $949M → $692M (-$257M)

Holders
225
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.92M
Puts
$727K
Net Calls
Net Calls Change

Top Buyers

1 +$20.7M
2 +$13.1M
3 +$12M
4
State Street
State Street
Massachusetts
+$11.1M
5
AllianceBernstein
AllianceBernstein
Tennessee
+$5.1M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$141M
2
$120M
3
$78.3M
4
$62.9M
5
$43.3M
6
$33.2M
7
$29.8M
8
$12.4M
9
$12.2M
10
$12M
11
$8.86M
12
$8.7M
13
$6.45M
14
$6.42M
15
$6.42M
16
$4.98M
17
$4.44M
18
$4.05M
19
$3.39M
20
$3.16M
21
$2.91M
22
$2.67M
23
$2.61M
24
$2.53M
25
$2.51M